Roberts Calvin W.

Alimera Sciences Inc

Director

Avg. Two Year Performance

(63%) Avg. Purchase Return (28%) Compound

14% Avg. Sale Return 7% Compound

Holdings: 141.44K shares

Last Three Months: 26-Aug-24 -- 25-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions